2 results match your criteria: "University Centre of Maritime Medicine and Tropical Disease in Gdynia[Affiliation]"
Article Synopsis
- * Data from 9800 patients showed that 81.7% had genotype 1b, with genotypes 3, 4, 1a, and 2 being less common; the distribution varied regionally within Poland.
- * Over time, the prevalence of genotype 1 has increased significantly (from 72.0% in 2003 to 87.5% in 2016), while there has been a decline in the prevalence of genotypes 3 and 4.
The Aim Of The Study: Was to analyze the efficacy achieved with regimens available for chronic hepatitis C (CHC) in Poland between 2013 and 2016.
Material And Methods: Data were collected from 29 centers and included 6786 patients with available sustained virologic response (SVR) data between 1 January 2013 and 31 March 2016.
Results: The sustained virologic response rate for genotypes (G) 1a, 1b, 2, 3 and 4 was 62%, 56%, 92%, 67% and 56% respectively; 71% patients ( = 4832) were treated with pegylated interferon α (Peg-IFNα) and ribavirin (RBV), with SVR rates of 58%, 49%, 92%, 67% and 55% respectively.